EUCTR2007-003085-17-GB进行中（未招募）1 期
The effect of insulin detemir on energy balance, postprandial nutrient handling, body fat distribution,and adipose tissue metabolism and gene expression in patients with type 2 diabetes. - Metabolic Effects of Detemir
niversity of Surrey0 个研究点目标入组 30 人开始时间: 2007年11月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. Informed consent
- •2. Type 2 diabetes mellitus
- •3. Treated with metformin
- •4. Already on treatment with twice-daily NPH insulin with or without short-acting insulin or a 'basal-bolus' regimen
- •5. Above 18 years of age
- •6. BMI 27-35
- •7. Able and willing to perform own blood glucose monitoring
- •8. Able and willing to maintain consistent eating habits throughout the entire study period
- •9. Able and willing to maintain consistent physical activity throughout the entire study period.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patients on sulphonylureas or thiazolidinediones
- •2. Proliferative retinopathy that has required acute treatment in the last 6 months
- •3. Impaired hepatic or renal function
- •4. Cardiac problems
- •5. Uncontrolled hypertension
- •6. Mental incapacity, unwillingness or a language barrier precluding adequate understanding or co-operation
- •7. Pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures.
研究者
相似试验
已完成
不适用
The effect of insulin detemir on energy balance, postprandial nutrient handling, body fat distribution and adipose tissue metabolism and gene expression in patients with type 2 diabetesTopic: Diabetes Research NetworkSubtopic: Type 2Disease: Insulin switch, MetabolicNutritional, Metabolic, EndocrineType 2 diabetesISRCTN72730583niversity of Surrey (UK)22
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusEUCTR2007-005317-19-GBovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - NDEUCTR2007-005317-19-ITOVO NORDISK940
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-FRovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-BEovo Nordisk A/S940